Christopher J. Schultz, MD

Christopher J. Schultz, MD, FACR, FASTRO

Chair and Bernard & Miriam Peck Family Professor of Radiation Oncology

Locations

Radiation Oncology

Contact Information

(414) 805-4472

Education

1985, Medical College of Wisconsin, MD

Biography

Training

Residency Radiation Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI (1989-1990)

Residency Radiation Oncology, Presbyterian Hospital, New York, NY (1986-1988)

Internship Children's Mercy Hospital, Kansas City, MO (1985-1986)

Certifications

Recertification, Radiation Oncology, American Board of Radiology (2000)

Board Certification, Radiation Oncology, American Board of Radiology (1990)

Patient Care Emphases

Head and neck cancer
Hodgkin's Disease
Low dose rate irradiation
Gamma Knife stereotactic radiosurgery
Lymphoma
Brain tumors

View Provider Profile

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.

(Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ.) Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):979-986 PMID: 32599030 SCOPUS ID: 2-s2.0-85089292279 07/01/2020
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.

(Bell EH, Zhang P, Shaw EG, Buckner JC, Barger GR, Bullard DE, Mehta MP, Gilbert MR, Brown PD, Stelzer KJ, McElroy JP, Fleming JL, Timmers CD, Becker AP, Salavaggione AL, Liu Z, Aldape K, Brachman DG, Gertler SZ, Murtha AD, Schultz CJ, Johnson D, Laack NN, Hunter GK, Crocker IR, Won M, Chakravarti A.) J Clin Oncol. 2020 Oct 10;38(29):3407-3417 PMID: 32706640 PMCID: PMC7527157 SCOPUS ID: 2-s2.0-85092564201 07/25/2020
4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience.

(Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA.) Clin Transl Radiat Oncol. 2020 Jul;23:72-79 PMID: 32490218 PMCID: PMC7256110 06/04/2020
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.

(de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM.) Front Oncol. 2020;10:1328 PMID: 33014774 PMCID: PMC7505056 10/06/2020
Improving Structure Delineation for Radiation Therapy Planning Using Dual-Energy CT.

(Noid G, Zhu J, Tai A, Mistry N, Schott D, Prah D, Paulson E, Schultz C, Li XA.) Front Oncol. 2020;10:1694 PMID: 32984048 PMCID: PMC7484725 09/29/2020
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy

(de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM.) Frontiers in Oncology. 7 September 2020;10 SCOPUS ID: 2-s2.0-85091425211 09/07/2020
Improving Structure Delineation for Radiation Therapy Planning Using Dual-Energy CT

(Noid G, Zhu J, Tai A, Mistry N, Schott D, Prah D, Paulson E, Schultz C, Li XA.) Frontiers in Oncology. 28 August 2020;10 SCOPUS ID: 2-s2.0-85090756213 08/28/2020
Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.

(Hall WA, Straza MW, Chen X, Mickevicius N, Erickson B, Schultz C, Awan M, Ahunbay E, Li XA, Paulson ES.) PLoS One. 2020;15(8):e0236570 PMID: 32764748 PMCID: PMC7413561 SCOPUS ID: 2-s2.0-85089301005 08/09/2020
4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience

(Paulson ES, Ahunbay E, Chen X, Mickevicius NJ, Chen GP, Schultz C, Erickson B, Straza M, Hall WA, Li XA.) Clinical and Translational Radiation Oncology. July 2020;23:72-79 SCOPUS ID: 2-s2.0-85084968086 07/01/2020
The transformation of radiation oncology using real-time magnetic resonance guidance: A review.

(Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ, MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium.) Eur J Cancer. 2019 11;122:42-52 PMID: 31614288 SCOPUS ID: 2-s2.0-85073099937 10/16/2019
Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer.

(Zenga J, Divi V, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz CJ, Shreenivas A, Wong S, Jackson RS, Pipkorn P.) Oral Oncol. 2019 11;98:125-131 PMID: 31586894 SCOPUS ID: 2-s2.0-85072773115 10/07/2019
The association between BMI and BSA-temozolomideinduced myelosuppression toxicities: A correlative analysis of NRG oncology RTOG 0525

(Robins HI, Eickhoff J, Gilbert MR, Armstrong TS, Shi W, De Groot JF, Schultz CJ, Hunter GK, Valeinis E, Roach M, Youssef EF, Souhami L, Howard SP, Lieberman FS, Herman JG, Zhang P, Mehta MP.) Neuro-Oncology Practice. 1 December 2019;6(6):473-478 SCOPUS ID: 2-s2.0-85079125614 12/01/2019